ChemoID Test Can Lead to Longer Glioblastoma Patient Survival
Researchers found that a cancer stem cell test called ChemoID can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma.
Category: Unknown Origin & Other Cancer Types
Unknown Origin & Other Cancer Types
Latest
Unknown Origin & Other Cancer Types
Latest
Black Patients Wait Longer for Uterine Cancer Testing, Diagnosis
Black patients are less likely to receive early diagnoses for uterine cancer than other racial and ethnic groups, according to new research.
Unknown Origin & Other Cancer Types
Latest
AI Liquid Biopsy Platform Shows Promise for Liver Cancer Detection
Positive liver cancer detection data demonstrates the promise of Delfi Diagnostics' liquid biopsy platform in a new tumor type.
Viome Life Sciences Unveils Test for Oral & Throat Cancer Detection
Viome Life Sciences, a biotechnology company, unveiled its CancerDetect test for oral & throat cancer, the first launch in a series of diagnostic tests in development.
Read More
New Research Could Lead to Simple Blood Test for Brain Tumors
University of Bristol research could lead to better detection of the most common type of malignant brain cancer.
Read More
Techcyte & Cytobay Partner for Bladder Cancer Non-Invasive Digital Diagnostic Test
Techcyte and Cytobay are collaborating on a non-invasive test aimed at enhancing bladder cancer surveillance.Â
Read More
Nanostics Launches Study to Identify Potent Disease Predictors for Early Bladder Cancer Detection
Nanostics launched a prospective clinical study designed to validate a novel and minimally invasive bladder cancer diagnostic test.
Read More
Researchers Develop Blood Test to Predict Liver Cancer Risk
Researchers developed a blood test to predict which patients with nonalcoholic fatty liver disease are most likely to develop liver cancer.
Read More
New Glycoproteomics Approach Quantifies Data Sets
Researchers introduced a new glycoproteomics approach called high-throughput intact glycopeptides quantitation strategy (HTiGQs).
Read More
Screening & Removal of Precancerous Lesions Prevents Anal Cancer
A new study found that routine screening for, and removal of, precancerous anal lesions can significantly reduce the risk of anal cancer.
Read More
Novel Assay for Early Detection of Ovarian Cancer Outperforms CA125, Research Shows
Mercy BioAnalytics’ Mercy Halo Ovarian Cancer assay outperformed CA125 when identifying those with early high-grade serious ovarian cancer.
Read More
A Blood Test May Help Detect Oral Cancer Early
Researchers used conductive polymer spray ionization mass spectrometry to screen blood tests for signs of oral squamous cell carcinoma.
Read More
Cell-Free DNA Methylation Predicts Chemo Benefit in Bladder Cancer
Methylation patterns in cfDNA from blood samples can help predict which patients with a type of bladder cancer may benefit from chemotherapy.
Read More
Alercell Distributes DNA-Based HPV Test
Molecular diagnostics company Alercell will distribute an HPV DNA based test kit, which is based on DNA sequencing analysis.
Read More
Test for Multiple Myeloma Provides Clues of a Rare, More Deadly Type
A test for the common blood cancer multiple myeloma can help patients identify if they have one of the most deadly forms of the cancer.
Read More
Biomarkers that Predict Response from Liver Cancer Immunotherapy Discovered
The biomarkers can predict a patient’s response to immunotherapy and the adverse events they may experience from the same immunotherapy.
Read More
Perception-Based Nanosensor Platform Could Advance Ovarian Cancer Detection
A team of researchers is working toward a new detection method for ovarian cancer, which uses machine learning techniques.
Read More
Handheld Device Could Painlessly Identify Skin Cancers
Researchers are developing a low-cost handheld device that could cut the rate of unnecessary skin biopsies in half.
Read More